About Us

A vertically integrated enterprise focused on industrial hemp cultivation, extraction, processing, and sales.

Scroll Down

KCBD BIOTECH
img
KCBD BIOTECH
2919

EU GMP production workshop 2,919 square meters

4530 mu

KCBD industrial hemp planted 4,350 mu (290 hectares)

50 tons

Output of CBD isolates 50 tons

100 million yuan

Investment Amount 100 million yuan


Founded in 2019, Heilongjiang Jinhetian Biotechnology Co., Ltd. is a full-industry chain enterprise integrating large-scale cultivation, extraction and processing, research and development, production and trade of cannabidiol (CBD) health consumer products.With a total investment of more than 80 million yuan, the factory covers an area of 22,245 square meters, EU GMP production workshop 2,919 square meters, and other supporting workshops 3,151 square meters.
Heilongjiang Province has unique natural conditions for industrial hemp cultivation.
In 2017, the cultivation, processing and sale of industrial hemp were legalized in Heilongjiang.In August 2024, six ministries and departments of the State jointly issued an announcement on the inclusion of cannabidiol and other substances in the management of Category II precursor chemicals in the non-drug category, further regulating the national legalization of the production, operation and management of the industrial hemp industry.

Core Facilities

KCBD focuses solely on wholesaling. Our product line covers Bulk lsolates & Distilates, Vaping Products, Skincare Products,Drinks, and foodstuff.


Plant Base


Heilongjiang Province has unique natural conditions for industrial hemp cultivation. Our annual output of CBD isolates is 50 tons, with an expected annual sales revenue of 170 million yuan and a profit of 50 million yuan, increasing local farmers' income by 30% and bringing significant social benefits.

R&D Center


The company has 42 employees, 11 professional research and development team.The company's technical team continuously innovates the research and development of product processes, applications and formulations, and develops new products with market competitiveness.

Production Workshop


The company has introduced domestic and foreign process equipment, including negative pressure automatic feeding system and low temperature countercurrent extraction system, to extract flower and leaf raw materials under ultra-low temperature conditions.The automatic DAC chromatographic separation system was adopted to realize the efficient separation of tetrahydrocannabinol (THC), group fraction and cannabidiol (CBD).The customized efficient tertiary molecular distillation system can significantly reduce the impurities in cannabidiol oil.The system is equipped with an automated control module that can monitor and adjust key parameters such as temperature, pressure and flow rate during the distillation process in real time to ensure the stability and reliability of the process.

Core Team


The core team of Heilongjiang Jinhetian Biotechnology Co., Ltd. is composed of a group of highly influential and professional elites in the field of biological science, mainly in the research and development department, production department, foreign sales department; They are the core driving force that drives the company to move steadily forward in the wave of cutting-edge biotechnology.

Accredited • Certified • Compliant

In 2017, the cultivation, processing, and sales of industrial hemp were legalized in Heilongjiang Province. In August 2024, six ministries jointly issued an announcement to include CBD among the substances managed under the category of non-medicine type II precursors, further standardizing the legalization of industrial hemp production, operation, and management. On September 4, 2024, the company obtained the "Registration Certificate for Production of Non-Medicine Type Precursors" and the "Registration Certificate for Trade of Non-Medicine Type Precursors" from the state.


Qualification
Qualification

Sales Layout

The Well-Rounded Wholesaler That Your Company Needs


We have signed procurement intention agreements with Dutch EWI Company, supplying them with no less than 20 tons of CBD crystals annually. We have also successfully entered into cooperation agreements with Thailand, Laos, Japan, and other countries regarding the development of downstream CBD crystal products, further expanding our market influence. Jinhetian Biotechnology has joined the European Hemp Association and the Dutch Hemp Association, expecting to complete the establishment of sales teams in Thailand, the U.S., and other places by the second half of 2024, actively positioning ourselves as suppliers to important pharmaceutical companies in the U.S. and Europe based on our production situation.

map